Albert Labs receives preliminary acceptance of 35 novel claims for patent protected manufacturing technology
The company's proprietary manufacturing methodology, developed and validated in-house at Albert Labs' Vancouver facility, facilitates the production and scaling of highly potent yields of its KRN Active Pharmaceutical Ingredient.